MaveMD: a functional data resource for genomic medicine

Abstract Variants of uncertain significance (VUS) have an unknown relationship with disease, undermining genetic medicine implementation. While multiplexed assays of variant effect (MAVEs) can help resolve VUS, major barriers prevent their routine clinical use. We present MaveMD (MAVEs for MeDicine; https://www.mavedb.org/mavemd ), a new MaveDB database interface that displays calibrated evidence strength, provides intuitive visualizations, integrates with established resources, and exports ready-to-use clinical evidence. MaveMD currently contains 476,076 variant effect measurements spanning 39 disease-associated genes, enabling classification of 75% of VUS. MaveMD supports future data generation efforts and the use of MAVE evidence in clinical practice, reducing VUS burden and improving outcomes.

Authors

Publication Details

Journal
Genome Medicine
Published
2026-09-29
DOI
https://doi.org/10.1186/s13073-026-01782-z
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

MaveMD: a functional data resource for genomic medicine

Douglas M. Fowler, Alan F. Rubin, Sally B. Grindstaff, Pankhuri Gupta et al.
Genome Medicine
Genomics and Rare Diseases
article

MaveMD: a functional data resource for genomic medicine

Douglas M. Fowler, Alan F. Rubin, Sally B. Grindstaff, Pankhuri Gupta, Malvika Tejura, Jeremy Stone, David Reinhart, Estelle Y. Da, Andrew B. Stergachis, Lea M. Starita, Abbye E. McEwen, Benjamin J. Capodanno, Nick Moore, Ashley E. Snyder
article en

Abstract

Abstract Variants of uncertain significance (VUS) have an unknown relationship with disease, undermining genetic medicine implementation. While multiplexed assays of variant effect (MAVEs) can help resolve VUS, major barriers prevent their routine clinical use. We present MaveMD (MAVEs for MeDicine; https://www.mavedb.org/mavemd ), a new MaveDB database interface that displays calibrated evidence strength, provides intuitive visualizations, integrates with established resources, and exports ready-to-use clinical evidence. MaveMD currently contains 476,076 variant effect measurements spanning 39 disease-associated genes, enabling classification of 75% of VUS. MaveMD supports future data generation efforts and the use of MAVE evidence in clinical practice, reducing VUS burden and improving outcomes.

Genome Medicine
Openalex Percentile: Top 12%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.